Fresh Tracks Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FRTX research report →
About the company
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U. S.
- CEO
- Albert Nicholas Marchio II
- IPO
- 1993
- Employees
- 4
- HQ
- Boulder, CO, US
Price Chart
- Market Cap
- $5.59M
- P/E
- -0.97
- P/S
- 0.70
- P/B
- 0.56
- EV/EBITDA
- 0.94
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -79.44%
- Net Margin
- -71.12%
- ROE
- -66.50%
- ROIC
- -64.05%
- Revenue
- $8.01M · 15.31%
- Net Income
- $-5,694,000 · 72.44%
- EPS
- $-0.96 · 86.96%
- Op Income
- $-6,360,000
- FCF YoY
- 77.59%
- 52W High
- $1.03
- 52W Low
- $0.03
- 50D MA
- $0.81
- 200D MA
- $0.81
- Beta
- 1.17
- Avg Volume
- 2.67K
Get TickerSpark's AI analysis on FRTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 24 | Exploration Capital, LLC | buy | 86,185 |
| Jun 7, 24 | Exploration Capital, LLC | buy | 319,315 |
| May 31, 24 | Exploration Capital, LLC | buy | 516 |
| May 30, 24 | Exploration Capital, LLC | buy | 9,838 |
| May 29, 24 | Exploration Capital, LLC | buy | 80 |
| May 23, 24 | Exploration Capital, LLC | buy | 15,627 |
| May 22, 24 | Exploration Capital, LLC | buy | 383 |
| May 21, 24 | Exploration Capital, LLC | buy | 6,879 |
| May 20, 24 | Exploration Capital, LLC | buy | 797 |
| May 16, 24 | Exploration Capital, LLC | buy | 73,768 |
Our FRTX coverage
Recent articles, reports, and earnings notes.
No research on FRTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FRTX report →Similar companies
Peers in the same neighborhood.